YOKOYAMA Hitoshi

Researcher Profile & Settings

Research

Overview of research:
We study widely on nephrology field including glomerulonephritis, nephrotic syndrome, acute and chronic renal failure and transplant related nephropathy. In addition, we study the clinical application of blood purification on refractory diseases including renal diseases, autoimmune diseases and systemic inflammatory diseases.

Education

• Kanazawa University Graduate School

Degree

• Ph.D in Medicine

Association Memberships

• 1993American Society of Nephrology member

Academic & Professional Experience

• Aug. 1992- Aug. 1993Harvard Medical School Lecturer on medicine

Research Activities

Published Papers

• Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia., Shinomiya Shohei, Nakase Keisuke, Fujii Ai, Takahara Yutaka, Adachi Hiroki, Okuro Masashi, Iinuma Yoshitsugu, Yokoyama Hitoshi, Ito Toru, Mizuno Shiro, SAGE open medical case reports, 9:1-5, Feb. 2021
  DOI:10.1177/2050313X21991063
• DNA damage in human glomerular endothelial cells induces nodular glomerulosclerosis via an ATR and ANXA2 pathway, Fujii A, Sunatani Y, Furuichi K, Fujimoto K, Adachi H, Iwabuchi K, Yokoyama H, Scientific Reports, 10:22206, Dec. 2020
• The revised version 2018 of the nationwide web-based registry system for kidney diseases in Japan: Japan Renal Biopsy Registry and Japan Kidney Disease Registry, (Ozeki T), Maruyama S, Nagata M, Shimizu A, Sugiyama H, Sato H, Yokoyama H, Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, Clinical and experimental nephrology, 24:1058-1068, Nov. 2020
• Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS), Yokoyama H, Yamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Furuichi K, Fujimoto K, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y, Clinical and experimental nephrology, 24:893-909, Oct. 2020
• A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR), (Katsuno T), Ito Y, Kagami S, Kitamura H, Maruyama S, Shimizu A, Sugiyama H, Sato H, Yokoyama H, Kashihara N, Clinical and experimental nephrology, 24:789-797, Sep. 2020
• Long-term retrospective observation study to evaluate effects of adiponectin on skeletal muscle in renal transplant recipients, Hiroki Adachi, Keiji Fujimoto, Ai Fujii, Keita Yamasaki, Keiichiro Okada, Toshikazu Matsuura, Kazuaki Okino, Kengo Furuichi, Hitoshi Yokoyama, Scientific Reports, 10:10723, Jul. 2020
• Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB), (Sofue T), Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M, Maruyama S, Wada T, Terada Y, Yamagata K, Narita I, Yanagita M, Sugiyama H, Shigematsu T, Ito T, Tamura K, Isaka Y, Okada H, Tsuruya K, Yokoyama H, Nakashima N, Kataoka H, Ohe K, Okada M, Kashihara N, PLoS One, 15:e0236132, Jul. 2020
• Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy, Furuichi K, Shimizu M, Yamanouchi M, Hoshino J, Sakai N, Iwata Y, Toyama T, Kitajima S, Hara A, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Yokoyama H, Wada T, BMJ Open Diabetes Research & Care, 8:e001157, Jun. 2020
• Incidence of Remission and Relapse of Proteinuria, End-Stage Kidney Disease, Mortality, and Major Outcomes in Primary Nephrotic Syndrome: The Japan Nephrotic Syndrome Cohort Study (JNSCS), (Ryohei Yamamoto), Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama , Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Toshinobu Sato, Takashi Wada, Hiroki Hayashi, Yasuhiro Akai, Megumu Fukunaga, Kazuhiko Tsuruya, Kosuke Masutani, Tsuneo Konta, Tatsuya Shoji, Takeyuki Hiramatsu, Shunsuke Goto, Hirofumi Tamai, Saori Nishio, Arimasa Shirasaki, Kojiro Nagai, Kunihiro Yamagata, Hajime Hasegawa, Hideo Yasuda, Shizunori Ichida, Tomohiko Naruse, Tomoya Nishino, Hiroshi Sobajima, Satoshi Tanaka, Toshiyuki Akahori, Takafumi Ito, Yoshio Terada , Ritsuko Katafuchi, Shouichi Fujimoto, Hirokazu Okada, Eiji Ishimura, Junichiro J Kazama, Keiju Hiromura, Tetsushi Mimura, Satoshi Suzuki, Yosuke Saka, Tadashi Sofue, Yusuke Suzuki, Yugo Shibagaki, Kiyoki Kitagawa, Kunio Morozumi, Yoshiro Fujita, Makoto Mizutani, Takashi Shigematsu, Naoki Kashihara, Hiroshi Sato, Seiichi Matsuo, Ichiei Narita, Yoshitaka Isaka, Clinical and experimental nephrology, 24:526-540, Jun. 2020
• J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan, (Naoki Nakagawa), Tadashi Sofue, Eiichiro Kanda, Hajime Nagasu, Kunihiro Matsushita, Masaomi Nangaku, Shoichi Maruyama, Takashi Wada, Yoshio Terada, Kunihiro Yamagata, Ichiei Narita, Motoko Yanagita, Hitoshi Sugiyama, Takashi Shigematsu, Takafumi Ito, Kouichi Tamura, Yoshitaka Isaka, Hirokazu Okada, Kazuhiko Tsuruya, Hitoshi Yokoyama, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Naoki Kashihara, Scientific Reports, 10:7351, Apr. 2020
• Comparison of the pain-reducing effects of EMLA cream and of lidocaine tape during arteriovenous fistula puncture in patients undergoing hemodialysis: A multi-center, open-label, randomized crossover trial, Fujimoto K, Adachi H, Yamazaki K, Nomura K, Saito A, Matsumoto Y, Igarashi K, Uranishi H, Sakaguchi S, Matsuura T, Imura J, Okino K, Mukai K, Okushi Y, Kagaya Y, Tsuruyama Y, Okada K, Miyatake N, Haraguchi T, Iida Y, Yokoyama H, PLoS One, 15:e0230372, Mar. 2020
• Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients, Nobuhiko Miyatake, Hiroki Adachi, Kanae Nomura-Nakayama, Keiichiro Okada, Kazuaki Okino, Norifumi Hayashi, Keiji Fujimoto, Kengo Furuichi, Hitoshi Yokoyama, PLoS One, 15:e0226526, Jan. 2020
• Changes in Double-Strand DNA Breaks Predict Delayed Graft Function (DGF) in Japanese Renal Allograft Recipients, Keiichiro Okada, Kanae Nomura-Nakayama, Yuki Okushi, Kazuaki Okino, Kiyotaka Mukai, Norifumi Hayashi, Keiji Fujimoto, Hiroki Adachi, Hitoshi Yokoyama, Clinical and Experimental Nephrology, 24:96-104, Jan. 2020
• Recent Clinicopathological Findings of Kidney Disease in Diabetes Cases, Kengo Furuichi, Hitoshi Yokoyama, Journal of Kanazawa Medical University, 44:117-121, Dec. 2019
• Plasma exchange for thrombotic microangiopathy secondary to dermatomyositis associated with acute kidney injury and complement activation: a case report with literature review, Norifumi Hayashi, Keiichirou Okada, Yuko Tsuruyama, Yu Kagaya, Sho Kumano, Yuki Ishikura,Kiminobu Takeda, Masayuki Nanbu, Keiji Fujimoto, Hiroki Adachi, Hitoshi Yokoyama, Renal Replacement Therapy, 5:48, Dec. 2019
• Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy, (Shimizu, M), Furuichi, K, Toyama, T, Funamoto, T, Kitajima, S, Hara, A, Iwata, Y, Sakai, N, Takamura, T, Kitagawa, K, Yoshimura, M, Kaneko, S, Yokoyama, H, Wada, T, Journal of diabetes investigation, 10:1041-1049, Jul. 2019
• Update of Findings of Hepatitis C Virus Infection in Renal Allograft Recipients, Kazuaki Okino, Yuki Okushi, Kiyotaka Mukai, Norifumi Hayashi, Keiji Fujimoto, Hiroki Adachi, Hitoshi Yokoyama, Journal of Kanazawa Medical University, 44:7-13, Jun. 2019
• Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study, (Yamanouchi M), Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T, Diabetes Care, 42:891-902, May 2019
• A case of apolipoprotein E Toyonaka and homozygous apolipoprotein E2/2 showing non-immune membranous nephropathy-like glomerular lesions with foamy changes, (Kato T), Ushiogi Y, Yokoyama H, Hara S, Matsunaga A, Muso E, Saito T, CEN Case Reports, 8:106-111, May 2019
• Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive Nephrosclerosis, (Kohagura K), Furuichi K, Kochi M, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T, American Journal of Hypertension, 32:486-491, Apr. 2019
• Epidemiology and prognosis of IgA nephropathy in Japan, Hitoshi Yokoyama, 77:593-597, Apr. 2019
• Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study, Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M, Narita I, Ninomiya T, Yokoyama H, Yokoo T, BMJ Open, 8:1-8, Nov. 2018
• Renal response to anaphylaxis in anesthetized rats and isolated perfused rat kidneys: roles of nitric oxide., Mukai K, Kuda Y, Shibamoto T, Tanida M, Kurata Y, Yokoyama H., The Journal of Physiological Sciences, 68:689-697, Sep. 2018
• Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015, Nakagawa N, Hasebe N, Hattori M, Nagata M, Yokoyama H, Sato H, Sugiyama H, Shimizu A, Isaka Y, Maruyama S, Narita I, Clinical and Experimental Nephrology, 22:797-807, Aug. 2018
• Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy, Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T, Clinical and Experimental Nephrology, 22:570-582, Jun. 2018
• Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis, Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hoshino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T, Clinical and Experimental Nephrology, 22:629-637, Jun. 2018
• Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia, Wada T, Muso E, Maruyama S, Hara A, Furuichi K, Yoshimura K, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Yokoyama H, Mori N, Yuzawa Y, Matsubara T, Tsukamoto T, Wada J, Ito T, Masutani K, Tsuruya K, Fujimoto S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Kobayashi S, Clinical and Experimental Nephrology, 22:591-596, Jun. 2018
• High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients, Nomura-Nakayama K, Adachi H, Miyatake N, Hayashi N, Fujimoto K, Yamaya H, Yokoyama H, PLoS One, 13:e0195066, May 2018
• Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS, (Miho.Shimizu), Kengo.Furuichi, Tadashi.Toyama, Tomoaki.Funamoto, Shinji.Kitajima, Akinori.Hara, Daisuke.Ogawa, Daisuke.Koya, Kenzo.Ikeda, Yoshitaka.Koshino, Yukie.Kurokawa, Hideharu.Abe, Kiyoshi.Mori, Masaaki.Nakayama, Yoshio.Konishi, Ken-ichi.Samejima, Masaru.Matsui, Hiroyuki.Yamauchi, Tomohito.Gohda, Kei.Fukami, Daisuke.Nagata, Hidenori.Yamazaki, Yukio.Yuzawa, Yoshiki.Suzuki, Shouichi.Fujimoto, Shoichi.Maruyama, Sawako.Kato, Takero.Naito, Kenichi.Yoshimura, Hitoshi.Yokoyama, Takashi.Wada, Research Group of Diabetic Nephropathy, The Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development, Clinical and Experimental Nephrology, 22:377-387, Apr. 2018
• Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes, Furuichi K, Yuzawa Y, Shimizu M, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Kimura K, Haneda M, Makino H, Matsuo S, Wada T, NEPHROLOGY DIALYSIS TRANSPLANTATION, 33:138-148, Jan. 2018
• Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy, N.Hayashi, K.Okada, Y.Matsui, K.Fujimoto, H.Adachi, H.Yamaya, M.Matsushita, H.Yokoyama, NEPHROLOGY DIALYSIS TRANSPLANTATION, 33:832-840, 2018
• Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients, Okushi Y, Okino K, Mukai K, Matsui Y, Hayashi N, Fujimoto K, Adachi H, Yamaya H, Yokoyama H, Clinical and Experimental Nephrology, 21:932-940, Mar. 2017
• The long-term outcomes of hepatitis C virus core antigen-positive Japanese renal allograft recipients, K.Okino, Y.Okushi, K.Mukai, Y.Matsui, N.Hayashi, K.Fujimoto, H.Adachi, H.Yamaya, H.Yokoyama, Clinical and Experimental Nephrology, 21:1113-1123, Mar. 2017
• The clinical and pathological characteristics of nephropathies in connective tissue diseases in the Japan Renal Biopsy Registry (J-RBR), (Ichikawa K), Konta T, Sato H, Ueda Y, Yokoyama H, Clinical and Experimental Nephrology, 21:1024-1029, Mar. 2017
• A patient with tuberous sclerosis in whom dialysis was introduced due to hemorrhaging from oncocytic papillary renal cell carcinoma, Keiji.Fujimoto, Masaru.Nakagawa, Katsuaki.Sato, Tatsuro.Tanaka, Nobuhiko.Miyatake, Keita.Yamazaki, Yuko.Tsuruyama, Yuki.Okushi, Kazuaki.Okino, Kiyotaka.Mukai, Katsuhito.Miyazawa, Hitoshi.Yokoyama, Journal of Japanese Society for Dialysis Therapy, 50:93-100, Jan. 2017
• Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome, (Saito T), Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Clinical and Experimental Nephrology, 21:961-970, 2017
• Clinical and histological features of lupus nephritis in Japan: A cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR), (Hiromura K), Ikeuchi H, Kayakabe K, Sugiyama H, Nagata M, Sato H, Yokoyama H, Nojima Y, Nephrology (Carlton), 22:885-891, 2017
• A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study, (Nishi S), Muso E, Shimizu A, Sugiyama H, Yokoyama H, Ando Y, Goto S, Fujii H, Clinical and Experimental Nephrology, 21:624-632, 2017
• Performance in adolescents of the two Japanese serum creatinine based estimated glomerular filtration rate equations, for adults and paediatric patients: A study of the Japan Renal Biopsy Registry and Japan Kidney Disease Registry from 2007 to 2013, (Uemura O), Yokoyama H, Ishikura K, Gotoh Y, Sato H, Sugiyama H, Honda M, Matsuo S, Nephrology (Carlton), 22:494-497, 2017
• Clinical manifestations of Henoch-Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR), (H.Komatsu), S.Fujimoto, N.Yoshikawa, H.Kitamura, H.Sugiyama, H.Yokoyama, Clinical and experimental nephrology, 20:552-560, Aug. 2016
  DOI:10.1007/s10157-015-1177-0
• Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015., H.Yokoyama, I.Narita, H.Sugiyama, M.Nagata, H.Sato, Y.Ueda, S.Matsuo, Clinical and experimental nephrology, 20:720-730, 2016
• Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients, H.Adachi, K.Nakayama, N.Hayashi, Y.Matsui, K.Fujimoto, H.Yamaya, H.Tonami, H.Yokoyama, PLoS one, 11:e0163899-e0163899, 2016
  DOI:10.1371/journal.pone.0163899
• Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version, (J.Usui), K.Yamagata, E.Imai, H.Okuyama, H.Kajiyama, H.Kanamori, S.Kaneko, E.Kono, Y.Sakai, N.Sakai, Y.Sakamaki, Y.Taniguchi, K.Nakai, H.Nishiwaki, S.Hirata, H.Yamaya, S.Tsuruoka, Y.Terada, H.Yokoyama, T.Wada, I.Narita, Clinical and experimental nephrology, 20:827-831, 2016
• Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese, N.Hayashi, S.Akiyama, H.Okuyama, Y.Matsui, H.Adachi, H.Yamaya, S.Maruyama, E.Imai, S.Matsuo, H.Yokoyama, Clinical and Experimental Nephrology, 19:797-803, Oct. 2015
  DOI:10.1007/s10157-014-1064-0
• DNA double-strand breaks induced intractable glomerular fibrosis in renal allografts, Y.Matsui, Y.Sunatani, N.Hayashi, K.Okino, Y.Okushi, K.Mukai, H.Adachi, H.Yamaya, K.Iwabuchi, H.Yokoyama, Clinical and Experimental Nephrology, 20:479-488, Sep. 2015
• Effects of serum albumin and glycated albumin levels on performance of the Japanese GFR equation based on serum cystatin C, (M.Horio), E.Imai, Y.Yasuda, T.Watanabe, H.Yokoyama, H.Makino, S.Matsuo, Clinical and Experimental Nephrology, 19:626-630, Aug. 2015
  DOI:10.1007/s10157-014-1038-2
• Clinical significance of serum and urinary soluble urokinase receptor (suPAR) in primary nephrotic syndrome and MPO-ANCA-associated glomerulonephritis in Japanese, K.Fujimoto, J.Imura, H.Atsumi, Y.Matsui, H.Adachi, H.Okuyama, H.Yamaya, H.Yokoyama, Clinical and Experimental Nephrology, 19:804-814, Aug. 2015
  DOI:10.1007/s10157-014-1067-x
• A prospective observational survey on the long-term effect of LDL apheresis on drug-resistant nephrotic Syndrome, (E. Muso), M.Mune, T.Hirano, M.Hattori, K.Kimura, T.Watanabe, H.Yokoyama, H.Sato, S.Uchida, T.Wada, T.Shoji, T.Takemura, Y.Yuzawa, S.Ogahara, S.Sugiyama, Y.Iino, S.Sakai, Y.Ogura, S.Yukawa, Y.Nishizawa, N.Yorioka, E.Imai, S.Matsuo, T.Saito, Nephron Extra, 5:58-66, Aug. 2015
• The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry, (Y.Yonekura), S.Goto, H.Sugiyama, H.Kitamura, H.Yokoyama, S.Nishi, Clinical and Experimental Nephrology, 19:359-370, Jun. 2015
  DOI:10.1007/s10157-014-0993-y
• Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR), H.Yokoyama, H.Sugiyama, i.Narita, T.Saito, K.Yamagata, S.Nishio, S.Fujimoto, N.Mori, Y.Yuzawa, S.Okuda, S.Maruyama, H.Sato, Y.Ueda, H.Makino, S.Matsuo, Clinical and Experimental Nephrology, 19:496-505, Jun. 2015
  DOI:10.1007/s10157-014-1022-x
• Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study, (Muso, Eri);Mune, Masatoshi;Hirano, Tsutomu;Hattori, Motoshi;Kimura, Kenjiro;Watanabe, Tsuyoshi;Yokoyama, Hitoshi;Sato, Hiroshi;Uchida, Shunya;Wada, Takashi;Shoji, Tetsuo;Yuzawa, Yukio;Takemura, Tsukasa;Sugiyama, Satoshi;Nishizawa, Yoshiki;Ogahara, Satoru;Yorioka, Noriaki;Sakai, Soichi;Ogura, Yosuke;Yukawa, Susumu;Iino, Yasuhiko;Imai, Enyu;Matsuo, Seiichi;Saito, Takao, Clinical and Experimental Nephrology, 19:379-386, Jun. 2015
  DOI:10.1007/s10157-014-0996-8
• Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine, (M.Horio), E.Imai, Y.Yasuda, T.Watanabe, H.Yokoyama, H.Makino, S.Matsuo, Clinical and Experimental Nephrology, 19:284-292, Apr. 2015
  DOI:10.1007/s10157-014-0988-8
• Serum tau protein as a marker of disease activity in enterohemorrhagic Escherichia coli O111-induced hemolytic uremic syndrome, (M.Kuroda), M.Shimizu, N.Inoue, I.Ikeno, H.Nakagawa, A.Yokoi, Y.Niida, M.Konishi, H.Kaneda, N.Igarashi, J.Yamahana, H.Taneichi, H.Kanegane, M.Ito, S.Saito, K.Furuichi, T.Wada, M.Nakagawa, H.Yokoyama, A.Yachie, Neurochemistry International, 85-86:24-30, 2015
  DOI:10.1016/j.neuint.2015.04.003
• Relapse and its remission in Japanese patients with idiopathic membranous nephropathy, (S.Kitajima), K.Furuichi, N.Sakai, A.Sagara, Y.Shinozaki, T.Toyama, Y.Iwata, M.Shimizu, H.Yokoyama, S.Kaneko, T.Wada, Clinical and Experimental Nephrology, 19:278-283, 2015
  DOI:10.1007/s10157-014-0987-9
• Different association of cigarette smoking with GFR estimated from serum creatinine and that from serum cystatin C in the general population, Y.Yamada, Y.Noborisaka, M.Ishizaki, M.Yamazaki, R.Honda, H.Yokoyama, T.Kakuma, Clinical and Experimental Nephrology, 19:669-677, 2015
  DOI:10.1007/s10157-014-1058-y
• Case of cutaneous phaeohyphomycosis caused by Phaeoacremonium sp. in a renal transplant recipient, Y.Sakata, A.Kitayama, R.Yoshimura, K.Anzawa, T.Fujii, K.Fujimoto, H.Yokoyama, T.Mochizuki, Journal of Dermatology, 42:263-266, 2015
• Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study, (K.Ando), K.Nitta, H.Rakugi, Y.Nishizawa, H.Yokoyama, T.Nakanishi, N.Kashihara, K.Tomita, M.Nangaku, K.Takahashi, M.Isshiki, T.Shimosawa, T.Fujita, International journal of medical sciences [electronic resource], 11:897-904:　, May 2014
• A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease, (T.Wada), M.Nangaku, S.Maruyama, E.Imai, K.Shoji, S.Kato, T.Endo, E.Muso, K.Kamata, H.Yokoyama, K.Fujimoto, Y.Obata, T.Nishino, H.Kato, S.Uchida, Y.Sasatomi, T.Saito, S.Matsuo, Kidney international., 85:641-648, Jan. 2014
• Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial, (T.Saito), M.Iwano, K.Matsumoto, T.Mitarai, H.Yokoyama, N.Yorioka, S.Nishi, A.Yoshimura, H.Sato, S.Ogahara, H.Shuto, Y.Kataoka, S.Ueda, A.Koyama, S.Maruyama, M.Nangaku, E.Imai, S.Matsuo, Y.Tomino, Clinical and experimental nephrology, 18:784-794, Dec. 2013
• Epidemiological and clinicopathological studies based on web registration system(J-RBR/J-KDR), H.Yokoyama, 26：37-43, Nov. 2013
• Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency, (M.Shimizu), K.Furuichi, H.Yokoyama, T.Toyama, Y.Iwata, N.Sakai, S.Kaneko, T.Wada, Clinical and experimental nephrology, 18:305-312, Oct. 2013
• A patient with persistent renal AL amyloid deposition after clinical remission by HDM/SCT therapy., H.Okuyama, H.Yamaya, T.Fukushima, H.Yokoyama, Clinical nephrology., 79:233-236, Mar. 2013
• Adult-onset renal failure in a family with Alagille syndrome with proteinuria and a novel JAG1 mutation., N.Hayashi, H.Okuyama, Y.Matsui, H.Yamaya, E.Kinoshita, H.Minato, Y.Niida, H.Yokoyama, Clinical kidney journal., 6:295-299, Mar. 2013
• Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010., (H.Sugiyama), H.Yokoyama, H.Sato, T.Saito, Y.Kohda, S.Nishi, K.Tsuruya, H.Kiyomoto, H.Iida, T.Sasaki, M.Higuchi, M.Hattori, K.Oka, S.Kagami, T.Kawamura, T.Takeda, H.Hataya, Y.Fukasawa, A.Fukatsu, K.Morozumi, N.Yoshikawa, A.Shimizu, H.Kitamura, Y.Yuzawa, S.Matsuo, Y.Kiyohara, K.Joh, M.Nagata, T.Taguchi, H.Makino, Clinical and experimental nephrology, 17:155-173, Feb. 2013
• Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation., (K.Furuichi), M.Shimizu, T.Toyama, D.Koya, Y.Koshino, H.Abe, K.Mori, H.Satoh, M.Imanishi, M.Iwano, H.Yamauchi, E.Kusano, S.Fujimoto, Y.Suzuki, S.Okuda, K.Kitagawa, Y.Iwata, S.Kaneko, S.Nishi, H.Yokoyama, Y.Ueda, M.Haneda, H.Makino, T.Wada, Clinical and experimental nephrology, 17:819-826, Feb. 2013
• Successful delivery in a patient with antineutrophil cytoplasmic antibody-associated glomerulonephritis., (M.Oshima), S.Kitajima, T.Toyama, A.Hara, K.Kitagawa, Y.Iwata, M.Shimizu, S.Nishio, J.Imura, H.Yokoyama, K.Furuichi, S.Kaneko, T.Wada, Internal medicine (Tokyo, Japan), 52:1605-1609, Feb. 2013
• The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan., Y.Noborisaka, M.Ishizaki, Y.Yamada, R.Honda, H.Yokoyama, M.Miyao, M.Tabata, Environmental Health and Preventive Medicine, 18:24-32, 2013
• Distribution of and factors contributing to chronic kidney disease in a middle-aged working population., Y.Noborisaka, M.Ishizaki, Y.Yamada, R.Honda, H.Yokoyama, M.Miyao, M.Tabata, Environmental Health and Preventive Medicine, 18：466-476, 2013
• Nodular lesions and mesangiolysis in diabetic nephropathy., (T.Wada), M. Shimizu, H.Yokoyama, Y. Iwata, Y. Sakai, S. Kaneko, K. Furuichi, Clinical and experimental nephrology, 17:3-9, 2013
• Progressive multifocal leukoencephalopathy developed 26 years,after renal transplantation., S.Nagayama, Y.Gondo, S.Araya, N.Minato, M.Fujita, M.Kaito, M.Nakanishi, K.Tanaka, H.Yamaya, H.Yokoyama, K.Nakamichi, M.Saijo, K.Okamoto, Y.Toyoshima, A.Kakita, M.Matsui, Clinical neurology and neurosurgery, 115:1482-1484, 2013
• Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR), H.Yokoyama, H.Sugiyama, H.Sato, T.Taguchi, M.Nagata, S.Matsuo, H.Makino, T.Watanabe, T.Saito, Y.Kiyohara, S.Nishi, H.Iida, K.Morozumi, A.Fukatsu, T.Sasaki, K.Tsuruya, Y.Kohda, M.Higuchi, H.Kiyomoto, S.Goto, M.Hattori, H.Hataya, S.Kagami, N.Yoshikawa, Y.Fukasawa, Y.Ueda, H.Kitamura, A.Shimizu, K.Oka, N.Nakagawa, T.Ito, S.Uchida, K.Furuichi, I.Nakaya, S.Umemura, K.Hiromura, M.Yoshimura, N.Hirawa, T.Shigematsu, M.Fukagawa, M.Hiramatsu,Y.Terada, O.Umemura, T.Kawata, A.Matsunaga, A.Kuroki, Y.Mori, K.Mitsuiki, H.Yoshida, Clinical and experimental nephrology, 16:903-920, Oct. 2012
• Circulating fibrocytes in ischemia-reperfusion injury and chronic renal allograft fibrosis, S.Kimura, M.Asaka, H.Atsumi, J.Imura, K.Fujimoto, Y.Chikazawa, M.Nakagawa, H.Okuyama, H.Yamaya, H.Yokoyama, Nephron. Clinical practice, 121:c16-c24, Sep. 2012
• Cytokine profiles of patients with enterohemorrhagic Escherichia coli O111-induced hemolytic-uremic syndrome, (M.Shimizu), M.Kuroda, N.Sakashita, M.Konishi, H.Kaneda, N.Igarashi, J.Yamahana, H.Taneichi, H.Kanegane, M.Ito, S.Saito, K.Ohta, T.Taniguchi, K.Furuichi, T.Wada, M.Nakagawa, H.Yokoyama, A.Yachie, Cytokine., 60:694-700, Aug. 2012
• A case of chronic hepatitis C with nephrotic diabetic nephropathy who achieved sustained viral remission by double-filtration plasmapheresis and interferon combination therapy, H.Okuyama, S.Kimura, K.Fujimoto, J.Imura, Y.Chikazawa, M.Nakagawa, H.Yamaya, H.Yokoyama, Internal medicine (Tokyo, Japan), 51:1991-1995, Apr. 2012
• Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR), H.Yokoyama, T.Taguchi, H.Sugiyama, H.Sato, Clinical and experimental nephrology, 16:557-563, Feb. 2012
• Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol, (T.Uzu), H.Yokoyama, H.Ito, D.Koya, A.Nakagawa, M.Nishizawa, H.Maegawa, Y.Yokomaku, S.Araki, A.Abiko, M.Haneda, Clinical and experimental nephrology, 15:58-63, Dec. 2011
• Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats, (K.Furuichi), Y.Hisada, M.Shimizu, T.Okumura, K.Kitagawa, K.Yoshimoto, Y.Iwata, H.Yokoyama, S.Kaneko, T.Wada, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association., 26:3124-3131, Mar. 2011
• Japan renal biopsy registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan, (H.Sugiyama), H.Yokoyama, H.Sato, T.Saito, Y.Kohda, S.Nishi, K.Tsuruya, H.Kiyomoto, H.Iida, T.Sasaki, M.Higuchi, M.Hattori, K.Oka, S.Kagami, M.Nagata, T.Kawamura, M.Honda, Y.Fukasawa, A.Fukatsu, K.Morozumi, N.Yoshikawa, Y.Yuzawa, S.Matsuo, Y.Kiyohara, K.Joh, T.Taguchi, H.Makino, Clinical and experimental nephrology, 15:493-503, Mar. 2011
• Cigarette smoking, proteinuria, and renal function in middle-aged Japanese men from an occupational population, Y.Noborisaka, M.Ishizaki, M.Nakata, Y.Yamada, R.Honda, H.Yokoyama, M.Miyao, M.Tabata, Environmental Health and Preventive Medicine, 17:147-156, 2011
• Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians, H.Yokoyama, H.Okuyama, H.Yamaya, Clinical and experimental nephrology, 15:321-330, 2011
• Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism, A.Saito, Y.Matsumoto, Y.Oyama, M.Asaka, H.Yokoyama, Therapeutic Apheresis and Dialysis, 14(1):98？103, Feb. 2010
• A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy, H.Atsumi, M.Asaka, S.Kimura, J.Imura, K.Fujimoto, Y.Chikazawa, M.Nakagawa, H.Okuyama, H.Yamaya, M.Moriyama, T.Tanaka, K.Suzuki, H.Yokoyama, Clinical transplantation, 24:35-38, Feb. 2010
• Long-term natural history of acquired cystic disease of the kidney, (I.Ishikawa), S.Hayama, K.Morita, T.Nakazawa, H.Yokoyama, R.Honda, K.Satoh, T.Kakuma, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy., 14:409-416, 2010
• Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism., A.Saito, Y.Matsumoto, Y.Oyama, M.Asaka, H.Yokoyama, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy., 14:98-103, 2010
• Revised equations for estimated GFR from serum creatinine in Japan, (S.Matsuo), E.Imai, M.Horio, Y.Yasuda, K.Tomita, K.Nitta, K.Yamagata, Y.Tomino, H.Yokoyama, A.Hishida, American journal of kidney diseases : the official journal of the National Kidney Foundation., 53:982-992, Jun. 2009
• The relationship between initial diagnosis and long-term prognosis in lupus nephritis, H.Okuyama, S.Kimura, H.Atsumi, J.Imura, K.Fujimoto, Y.Chikazawa, M.Nakagawa, H.Imamura, H.Yamaya, M.Asaka, N.Tomosugi, H.Yokoyama, 51：44-50, Jan. 2009
• Prophylactic continuous hemodialysis after coronary angiography in patients wit renal insufficiency, (K.Sato), M.Asaka, M.Nakagawa, H.Imamura, H.Yokoyama, I.Ishikawa, 42：237-243, 2009
• Prevalence of chronic kidney disease in the Japanese general poulation, (E.Imai), M.Horio, T.Watanabe, K.Iseki, K.Yamagata, S.Hara, N.Ura, Y.Kiyohara, T.Moriyama, Y.Ando, S.Fujimoto, T.Konta, H.Yokoyama, H.Makino, A.Hishida, S.Matsuo, Clinical and experimental nephrology, 13:621-630, 2009
• Urinalysis in chronic kidney diseases, H.Yokoyama, H.Yamaya, 66：1713-1718, Sep. 2008
• A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis, M.Nakagawa, S.Kimura, K.Fujimoto, H.Atsumi, J.Imura, Y.Chikazawa, H.Imamura, H.Okuyama, H.Yamaya, T.Fukushima, A.Nakagawa, M.Asaka, H.Yokoyama, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy., 12:509-513, Jan. 2008
• Ischemia-reperfusion injury as the leading cause of primary non-function in renal transplantation using donors with prolonged warm ischemic time, M.Asaka, H.Imamura, K.Sato, H.Atsumi, H.Okuyama, H.Yamaya, H.Yokoyama, I.Ishikawa, Clinical transplantation, 22(Suppl 19):19-24, 2008
• Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in Japanese patients on chronic non-reuse hemodialysis:a prospective cohort study from the J-DOPPS II study, H.Yokoyama, T.Kawaguchi, T.Wada, Y.Takahashi, T.Higashi, S.Yamazaki, S.Fukuhara, T.Akiba, T.Akizawa, Y.Asano, K.Kurokawa, A.Saito, Nephron. Clinical practice, 109:c100-ｃ108, 2008
• Blockade of IP-10/CXCR3 promotes progressive renal fibrosis, (I.Nakaya), T.Wada, K.Furuichi, N.Sakai, K.Kitagawa, H.Yokoyama, Y.Ishida, T.Kondo, T.Sugaya, H.Kawachi, F.Shimizu, S.Narumi, M.Haino, C.Gerard, K.Matsushima, S.Kaneko, Nephron. Experimental nephrology, 107:e12-e21, Jul. 2007
• Advances in apheresis therapy for glomerular diseases, H.Yokoyama, T.Wada, W.Zhang, H.Yamaya, M.Asaka, Clinical and experimental nephrology, 11:122-127, Jan. 2007
• Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels, (Y.Iwata), T.Wada, H.Yokoyama, T,Toyama, S.Kitajima, T.Okumura, A.Hara, J.Yamahana, I.Nakaya, M.Kobayashi, K.Kitagawa, S.Kokubo, K.Yoshimoto, K.Shimizu, N.Sakai, K.Furuichi, Y.Koshino, S.Takeda, K.Takasawa, S.Ohta, M.Takaeda, C.Takaeda, S.Kaneko, Internal medicine (Tokyo, Japan), 447-452, 2007
• Rituximab therapy for epstein-barr virus-related chronic hepatitis following living donor kidney transplantation, (K.Ohta), M.Shimizu, A.Nakai, T.Toma, Y.Kasahara, C.Arii, A.Yachie, T.Kawamura, A.Aikawa, A.Hasegawa, K.Sato, H.Yokoyama, I.Ishikawa, S.Koizumi, American journal of kidney diseases : the official journal of the National Kidney Foundation., 48:986-989, Dec. 2006
• Secondary lymphoid tissus chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis, (N.Sakai), T.Wada, H.Yokoyama, M.Lipp, S.Ueha, K.Matsushima, S.Kaneko, Proceedings of the National Academy of Sciences of the United States of America, 103:14098-14103, Sep. 2006
• TAK-603, an anti-inflammatory compound, reduces crescentic glomerulonephritis and preserves renal function in WKY rats, (J.Yamahana), T.Wada, K.Furuichi, N.Sakai, H.Yokoyama, S.Kaneko, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association., 21:2736-2744, Aug. 2006
• Remission of IgA nephropathy after allogeneic peripheral blood stem cell transplantation followed by immunosuppression for acute lymphocytic leukemia, (Y.Iwata), T.Wada, A.Uchiyama, A.Miwa, I.Nakaya, T.Tohyama, Y.Yamada, T.Kurokawa, T.Yoshida, S.Ohta, H.Yokoyama, H.Iida, Internal medicine (Tokyo, Japan), 45:1291-1295, Aug. 2006
• Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and PMMA) during hemodialysis treatment using SELDI-TOF-MS, I.Ishikawa, Y.Chikazawa, K.Sato, M.Nakagawa, H.Imamura, S.Hayama, H.Yamaya, M.Asaka, N.Tomosugi, H.Yokoyama, K.Matsumoto, American journal of nephrology, 26:372-380, Jun. 2006
• Reduction in chronic allograft nephropathy by inhibition of p38 mitogen-activated protein kinase, (T.Wada), H.Azuma, K.Furuichi, N.Sakai, K.Kitagawa, Y.Iwata, K.Matsushima, S.Takahara, H.Yokoyama, S.Kaneko, American journal of nephrology, 26:319-325, 2006
• The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese., Kidney international., 66:2382-2388, Dec. 2004
• Immunomodulation effects and clinical evidence of apheresis in renal diseases., Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy., 7:513-519, Dec. 2003
• Chemokines in renal fibrosis and glomerulosclerosis., Current Med Literature Nephrology and Hypertension, 9(4):89-96, Nov. 2003
• Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR), (Urushihara M), Sato H, Shimizu A, Sugiyama H, Yokoyama H, Hataya H, Matsuoka K, Okamoto T, Ogino D, Miura K, Hamada R, Hibino S, Shima Y, Yamamura T, Kitamoto K, Ishihara M, Konomoto T, Hattori M; the Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology., Clinical and Experimental Nephrology, 25:1018-1026, May 2021
• Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia, (Wada T), Hara A, Muso E, Maruyama S, Kato S, Furuichi K, Yoshimura K, Toyama T, Sakai N, Suzuki H, Tsukamoto T, Miyazaki M, Sato E, Abe M, Shibagaki Y, Narita I, Goto S, Sakamaki Y, Yokoyama H, Mori M, Tanaka S, Yuzawa Y, Hasegawa M, Matsubara T, Wada J, Tanabe K, Ito T, Masutani K, Abe Y, Tsuruya K, Fujimoto S, Iwatsubo S, Tsuda A, Suzuki H, Kasuno K, Terada Y, Nakata T, Iino N, Sofue T, Miyata H, Nakano T, Ohtake T, Kobayashi S: LICENSE study Group, Clinical and experimental nephrology, 25:1-8, 2021
• Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab, Keiji Fujimoto, Yu Kagaya, Syo Kumano, Ai Fujii, Yuko Tsuruyama, Toshikazu Matsuura, Keita Yamazaki, Kanae Nomura, Keiichiro Okada, Kazuaki Okino, Hiroki Adachi, Kengo Furuichi, Hitoshi Yokoyama, Clinical Nephrology, 95:29-36, 2021
• Association between anti-complement factor H antibodies and renal outcome in primary membranous nephropathy, Yu Kagaya, Norifumi Hayashi, Keiji Fujimoto, Hiroki Adachi, Kengo Furuichi, Hitoshi Yokoyama, Clinical Nephrology, 96:82-89, Aug. 2021
• Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy, (Miho Shimizu), Kengo Furuichi , Shinji Kitajima , Tadashi Toyama , Megumi Oshima , Hisayuki Ogura , Koichi Sato , Shiori Nakagawa , Yuta Yamamura , Taro Miyagawa , Akinori Hara , Yasunori Iwata , Norihiko Sakai , Kiyoki Kitagawa , Mitsuhiro Yoshimura , Hitoshi Yokoyama , Takashi Wada, BMC nephrology, 22:319, Sep. 2021
• Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease, (Masayuki Yamanouchi ), Kengo Furuichi , Junichi Hoshino , Tadashi Toyama , Miho Shimizu , Yuta Yamamura , Megumi Oshima , Shinji Kitajima , Akinori Hara , Yasunori Iwata , Norihiko Sakai , Yuki Oba , Shusaku Matsuoka , Daisuke Ikuma , Hiroki Mizuno , Tatsuya Suwabe , Naoki Sawa , Yukio Yuzawa , Hiroshi Kitamura , Yoshiki Suzuki , Hiroshi Sato , Noriko Uesugi , Yoshihiko Ueda , Shinichi Nishi , Hitoshi Yokoyama , Tomoya Nishino , Kenichi Samejima , Kentaro Kohagura , Yugo Shibagaki , Hirofumi Makino , Seiichi Matsuo , Yoshifumi Ubara , Takashi Wada, BMJ open diabetes research care, 9:e002241, Aug. 2021
• Effect of sutureless securement on hemodialysis catheter-related bloodstream infection, Keiji Fujimoto , Emi Iida , Syo Kumano , Ai Fujii , Hiroki Adachi , Kengo Furuichi , Hitoshi Yokoyama, Scientific reports, 11:21771, Nov. 2021
• Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression, and proteinuria remission, (Takehiko Kawaguchi ), Toshiyuki Imasawa , Moritoshi Kadomura, Hiroshi Kitamura, Shoichi Maruyama, Takaya Ozeki, Ritsuko Katafuchi, Kazumasa Oka , Yoshitaka Isaka, Hitoshi Yokoyama, Hitoshi Sugiyama, Hiroshi Sato, Nephrology dialysis transplantation, gfab267:10.1093/ndt/gfab267, Sep. 2021
• Evaluation of the Utility of Angiotensin Receptor Blockers for Renal Protection in Japanese Renal Allograft Recipients, Yuki Okushi, Kazuaki Okino, Kiyotaka Mukai, Norifumi Hayashi, Keiji Fujimoto, Hiroki Adachi, Kengo Furuichi, Hitoshi Yokoyama, JOURNAL OF KANAZAWA MEDICAL UNIVERSITY, 46:7-18, Jun. 2021
• Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study, (Masayuki Yamanouchi), Kengo Furuichi, Miho Shimizu, Tadashi Toyama, Yuta Yamamura, Megumi Oshima, Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Yuki Oba, Shusaku Matsuoka, Daisuke Ikuma, Hiroki Mizuno, Tatsuya Suwabe, Junichi Hoshino, Naoki Sawa, Yukio Yuzawa, Hiroshi Kitamura, Yoshiki Suzuki, Hiroshi Sato, Noriko Uesugi, Yoshihiko Ueda, Shinichi Nishi, Hitoshi Yokoyama, Tomoya Nishino, Kenichi Samejima, Kentaro Kohagura, Yugo Shibagaki, Hirofumi Makino, Seiichi Matsuo, Yoshifumi Ubara, Takashi Wada, the Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development, Nephrology Dialysis Transplantation, gfab185:10.1093/ndt/gfab185, May 2021
• Clinical manifestations of focal segmental glomerulosclerosis in Japan from the Japan Renal Biopsy Registry: age stratification and comparison with minimal change disease, (Takaya Ozeki) , Shoichi Maruyama , Toshiyuki Imasawa , Takehiko Kawaguchi , Hiroshi Kitamura , Moritoshi Kadomura , Ritsuko Katafuchi , Kazumasa Oka , Hitoshi Yokoyama , Hitoshi Sugiyama , Hiroshi Sato, Scientific Reports, 11:2602, Jan. 2021
• Nationwide Survey of Post-Transplant Glomerular Diseases, Based on the Japan Renal Biopsy Registry (J-RBR), (Joichi Usui) , Kunihiro Yamagata , Michio Nagata , Akira Shimizu , Asami Takeda , Hitoshi Sugiyama , Hiroshi Sato , Hitoshi Yokoyama, Annals of transplantation, 26:e931873, May 2021
• Rapidly progressive kidney dysfunction and crystal casts associated with adenine phosphoribosyltransferase (APRT) deficiency-lessons for the clinical nephrologist, Keita Yamazaki , Katsuhito Miyazawa , Yo Nida , Kengo Furuichi , Hitoshi Yokoyama, Journal of nephrology, 34:2147-2149, Dec. 2021
• Role and expression of non-classical human leukocyte antigen-G in renal transplanted allografts, Kumano S, Okushi Y, Fujimoto K, Adachi H, Furuichi K, Yokoyama H, Clinical and experimental nephrology, 25(4):428-438, Jan. 2021
• Steroid-sensitive recurrent mesangial proliferative glomerulonephritis with monoclonal IgG deposits, Nomura K, Miyatake N, Okada K, Hayashi N, Fujimoto K, Adachi H, Furuichi K, Shimizu A, Yokoyama H, CEN Case Reports, 10(2):308-313, Jan. 2021
• Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR), (Maki Urushihara), Hiroshi Sato, Akira Shimizu, Hitoshi Sugiyama, Hitoshi Yokoyama, Hiroshi Hataya, Kentaro Matsuoka, Takayuki Okamoto, Daisuke Ogino, Kenichiro Miura, Riku Hamada, Satoshi Hibino, Yuko Shima, Tomohiko Yamamura, Koichi Kitamoto, Masayuki Ishihara, Takao Konomoto, Motoshi Hattori, the Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, Clinical and Experimental Nephrology, 25:1018-1026, Sep. 2021
  DOI:doi:10.1007/s10157-021-02077-w
• Early, Noninvasive Clinical Indicators of Kidney Prognosis in Primary Nephrotic Syndrome: A Retrospective Exploratory Study., Fujimoto K, Haraguchi T, Kumano S, Yamazaki K, Miyatake N, Nomura K, Mukai K, Okino K, Hayashi N, Adachi H, Yokoyama H, Iida Y, Furuichi K., International Journal of Nephrology, 2022:Article ID 2718810, Aug. 2022
• Association between expanded criteria for living kidney donors and renal biopsy findings, (Shunsuke Goto), Hideyo Oguchi, Ken Sakai, Tetsuo Mikami, Daisuke Ichikawa, Masahiko Yazawa, Junki Koike, Kengo Furuichi, Masahiko Kawabata, Hitoshi Yokoyama, Tadashi Sofue, Emi Ibuki, Shinichi Nishi, Journal of Nephrology, 35:1809-1818, Jan. 2022
• Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study, (Yamamoto R), Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Tsukamoto T, Uchida S, Tsuruya K, Shoji T, Hayashi H, Akai Y, Fukunaga M, Konta T, Nishio S, Goto S, Tamai H, Nagai K, Katafuchi R, Masutani K, Wada T, Nishino T, Shirasaki A, Sobajima H, Nitta K, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Akahori T, Naruse T, Hiramatsu T, Morozumi K, Mimura T, Saka Y, Ishimura E, Hasegawa H, Ichikawa D, Shigematsu T, Sato H, Narita I, Isaka Y; Japan Nephrotic Syndrome Cohort Study investigators, Journal of Nephrology, 35:1135-1144, Apr. 2022
• Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR), (Keiichi Sumida), Asami Takeda, Kengo Furuichii, Noriko Uesugi, Yoshifumi Ubara, Hiroshi Sato, Hitoshi Sugiyama, Akira Shimizu, Hitoshi Yokoyama, Clinical and Experimental Nephrology, 26:325
• Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study, (Ryohei Yamamoto), Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Asami Takeda, Shunya Uchida, Tatsuo Tsukamoto, Kazuhiko Tsuruya, Yasuhiro Akai, Kosaku Nitta, Megumu Fukunaga, Hiroki Hayashi, Kosuke Masutani , Takashi Wada, Tsuneo Konta, Ritsuko Katafuchi, Saori Nishio, Shunsuke Goto, Hirofumi Tamai, Arimasa Shirasaki, Tatsuya Shoji, Kojiro Nagai, Tomoya Nishino, Kunihiro Yamagata, Junichiro J Kazama, Keiju Hiromura, Hideo Yasuda, Makoto Mizutani, Tomohiko Naruse, Takeyuki Hiramatsu, Kunio Morozumi, Hiroshi Sobajima, Yosuke Saka, Eiji Ishimura, Daisuke Ichikawa, Takashi Shigematsu, Tadashi Sofue, Shouichi Fujimoto, Takafumi Ito, Hiroshi Sato, Ichiei Narita, Yoshitaka Isaka; JNSCS Investigators, Scientific Reports, 12:9782, Jun. 2022
• Clinical and pathological characteristics of patients with acute kidney injury in Japan in whom kidney biopsy was performed: a cross-sectional analysis of the Japan Renal Biopsy Registry (J‑RBR), (Norihito Moniwa), Marenao Tanaka, Hiroshi Sato, Akira Shimizu, Hitoshi Sugiyama, Hitoshi Yokoyama, Kazuhiko Tsuruya, Akinori Hashiguchi; Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, Clinical and Experimental Nephrology, 26:963-973, May 2022
• A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan, (Hidekazu Ikeuchi), Hitoshi Sugiyama, Hiroshi Sato, Hitoshi Yokoyama, Shoichi Maruyama, Masashi Mukoyama, Hiroki Hayashi, Tatsuo Tsukamoto, Michio Fukuda, Kunihiro Yamagata, Eiji Ishikawa, Keiko Uchida, Yuji Kamijo, Naoki Nakagawa, Kazuhiko Tsuruya, Yoshihisa Nojima, Keiju Hiromura, Clinical and Experimental Nephrology, 26:898-908, May 2022
• Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS), (Tomonori Kimura), Ryohei Yamamoto, Mitsuaki Yoshino, Ryuichi Sakate, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Kosaku Nitta, Tatsuo Tsukamoto, Shunya Uchida, Asami Takeda, Toshinobu Sato, Takashi Wada, Hiroki Hayashi, Yasuhiro Akai, Megumu Fukunaga, Kazuhiko Tsuruya, Kosuke Masutani, Tsuneo Konta, Tatsuya Shoji, Takeyuki Hiramatsu, Shunsuke Goto, Hirofumi Tamai, Saori Nishio, Kojiro Nagai, Kunihiro Yamagata, Hideo Yasuda, Shizunori Ichida, Tomohiko Naruse, Tomoya Nishino, Hiroshi Sobajima, Toshiyuki Akahori, Takafumi Ito, Yoshio Terada, Ritsuko Katafuchi, Shouichi Fujimoto, Hirokazu Okada, Tetsushi Mimura, Satoshi Suzuki, Yosuke Saka, Tadashi Sofue, Kiyoki Kitagawa, Yoshiro Fujita, Makoto Mizutani, Naoki Kashihara, Hiroshi Sato, Ichiei Narita, Yoshitaka Isaka, 26:1170-1179, Dec. 2022
• Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function, (Muso E), Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Saito T, Mune M, Sugiyama S, Iino Y, Hirano T, Hattori M, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Oda H, Mori K, Kimura H, Ito O, Nishiyama A, Maruyama S, Inagi R, Fujimoto S, Tsukamoto T, Suzuki Y, Honda H, Babazono T, Tsuruya K, Yuzawa, 26:220-228, Feb. 2022
  DOI:doi: 10.1111/1744-9987.13694.
• Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study, (Masayuki Yamanouchi), Kengo Furuichi, Miho Shimizu, Tadashi Toyama, Yuta Yamamura, Megumi Oshima, Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Yuki Oba , Shusaku Matsuoka, Daisuke Ikuma, Hiroki Mizuno, Tatsuya Suwabe, Junichi Hoshino, Naoki Sawa, Yukio Yuzawa, Hiroshi Kitamura, Yoshiki Suzuki, Hiroshi Sato, Noriko Uesugi, Yoshihiko Ueda, Shinichi Nishi, Hitoshi Yokoyama, Tomoya Nishino, Kenichi Samejima, Kentaro Kohagura, Yugo Shibagaki, Hirofumi Makino, Seiichi Matsuo, Yoshifumi Ubara, Takashi Wada, 37:489-497, Feb. 2022
• A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry, (Makoto Nasu), Naoki Nakagawa, Shigeo Hara, Junko Yano, Yuka Kurokawa, Nao Nakamura, Hitoshi Yokoyama, Akira Shimizu, Hitoshi Sugiyama, Hiroshi Sato, Kei Fukami, Clinical and Experimental Nephrology, 27:141-150, Feb. 2023
  DOI:DOI: 10.1007/s10157-022-02287-w
• Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study, (Miho Shimizu), Kengo Furuichi, Tadashi Toyama, Masayuki Yamanouchi, Junichi Hoshino, Shinji Kitajima , Akinori Hara, Yasunori Iwata, Norihiko Sakai, Yukio Yuzawa, Hiroshi Kitamura, Hiroshi Sato, Yugo Shibagaki, Yoshiki Suzuki, Noriko Uesugi, Yoshihiko Ueda, Kentaro Kohagura, Kenichi Samejima, Kazuhiko Tsuruya, Shinichi Nishi, Tomoya Nishino, Hirofumi Makino, Seiichi Matsuo, Yoshifumi Ubara, Hitoshi Yokoyama, Takashi Wada; Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development, Journal of Diabetes Investigation, 14:1268-1278, Nov. 2023
  DOI:doi: 10.1111/jdi.14059
• Seasonal variations in renal biopsy numbers and primary glomerular disease features based on the Japan renal biopsy registry, (Go Kanzaki), Nobuo Tsuboi, Takashi Yokoo, Noriko Uesugi, Kengo Furuichi, Akira Shimizu, Hitoshi Sugiyama, Hiroshi Sato, Hitoshi Yokoyama; Committee for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, Scientific Reports, 23:5223, May 2023
  DOI:DOI: 10.1038/s41598-023-32182-7
• Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017, (Kazunori Goto), Takahiro Imaizumi , Riku Hamada, Kenji Ishikura, Tomoki Kosugi, Ichiei Narita, Hitoshi Sugiyama, Akira Shimizu, Hitoshi Yokoyama, Hiroshi Sato, Shoichi Mauryama, Journal of Nephrology, 8:2257-2267, Aug. 2023
  DOI:DOI: 10.1007/s40620-023-01687-9
• A Case of Spontaneous Remission of Membranous Nephropathy After the Removal of Nerve Epidermal Growth Factor-Like 1 Positive Sigmoid Colon Carcinoma, Ai Fujii, Norifumi Hayashi, Hideto Fujita, Hitoshi Yokoyama, Kengo Furuichi, Cureus, 15:e49892, Dec. 2023
  DOI:10.7759/cureus.49892
• Case report of systemic sclerosis: Uncommon manifestation of nephrotic syndrome post-renal crisis, Ai Fujii, Takaya Kondo, Yasutaka Katsura, Sho Kumano, Serina Kita, Kazutoshi Nomura, Tomohisa Yabe, Norifumi Hayashi, Keiji Fujimoto, Hitoshi Yokoyama and Kengo Furuichi, 11:1-4, Dec. 2023
  DOI:doi.org/10.1177/2050313X231220801
• Nephrotic syndrome with rectus sheath hematoma: a case report, Ai Fujii, Yuto Matsuda, Tomohisa Yabe, Hayashi Norifumi, Keiji Fujimoto, Masahide Yamazaki, Hitoshi Yokoyama, Kengo Furuichi, Journal of Medical Case Reports, 18:148, Mar. 2024
• Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia, (Akinori Hara), Takashi Wada, Eri Muso, Shoichi Maruyama, Sawako Kato, Kengo Furuichi, Kenichi Yoshimura, Tadashi Toyama, Norihiko Sakai, Hiroyuki Suzuki, Tatsuo Tsukamoto, Mariko Miyazaki, Eiichi Sato, Masanori Abe, Yugo Shibagaki, Ichiei Narita, Shin Goto, Yuichi Sakamaki, Hitoshi Yokoyama, Noriko Mori, Satoshi Tanaka, Yukio Yuzawa, Midori Hasegawa, Takeshi Matsubara, Jun Wada, Katsuyuki Tanabe, Kosuke Masutani, Yasuhiro Abe, Kazuhiko Tsuruya, Shouichi Fujimoto, Shuji Iwatsubo, Akihiro Tsuda, Hitoshi Suzuki, Kenji Kasuno, Yoshio Terada, Takeshi Nakata, Noriaki Iino, Tadashi Sofue, Hitomi Miyata, Toshiaki Nakano, Takayasu Ohtake, Shuzo Kobayashi; LICENSE study group, Blood Purification, 52:373-381, May 2023
• A Case of Sjo¨gren’s Syndrome Complicated with Intestinal and Retroperitoneal Emphysema during Glucocorticoid Treatment for Interstitial Nephritis, Ai Fujii, Megumi Sakuma, Yuto Matsuda, Mizuki Hayashi, Takaya Kondo, Serina Kita, Shinichiro Nakao, Yui Kusuno, Kazutoshi Nomura, Tomohisa Yabe, Keita Yamazaki, Keiichiro Okada, Norifumi Hayashi, Keiji Fujimoto, Hitoshi Yokoyama, Kengo Furuichi, JOURNAL OF KANAZAWA MEDICAL UNIVERSITY, 49:31-34, Mar. 2024